Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mohamed A. Hussein
Observed names:
Hussein, Mohamed,
M. HUSSEIN,
M. Hussein,
Mohamed Hussein
Institutions:
New York Medical College,
Regeneron (United States)
Observed institutions:
New York Medical College,
Regeneron (United States),
Hamilton General Hospital,
IQVIA (United States),
Humana (United States),
McMaster University
show all 6
ORCID:
0000-0002-6138-7021
Observed ORCID:
0000-0002-6138-7021
OpenAlex ID:
A5101651441
Cost of atrial fibrillation in United States managed care organizations
2009
·
Michael H. Kim
, Jay Lin
, et al.
·
Advances in Therapy
·
90
Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: A retrospective database analysis
2004
·
Daniel R. Vanderpoel
, Mohamed A. Hussein
, et al.
·
Clinical Therapeutics
·
86
Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti‐diabetic medication: a follow‐up study
2012
·
M. Wenten
, J. A. Gaebler
, et al.
·
Diabetic Medicine
·
77
PDF
Rates of venous thromboembolism occurrence in medical patients among the insured population
2009
·
Mohamed Hussein
, Jay Lin
, et al.
·
Thrombosis and Haemostasis
·
69
Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes
2010
·
Steven B. Deitelzweig
, Jay Lin
, et al.
·
Advances in Therapy
·
53
Thematic analysis to explore patients’ experiences with long COVID-19: a conceptual model of symptoms and impacts on daily lives
2024
·
Diana Rofail
, Selin Somersan-Karakaya
, et al.
·
BMJ Open
·
26
PDF
Venous Thromboembolism Pharmacy Intervention Management Program With an Active, Multifaceted Approach Reduces Preventable Venous Thromboembolism and Increases Appropriate Prophylaxis
2011
·
Charles E. Mahan
, Mohamed A. Hussein
, et al.
·
Clinical and Applied Thrombosis/Hemostasis
·
25
PDF
Association between allergic conditions and COVID-19 susceptibility and outcomes
2024
·
Chao Chen
, Xue Song
, et al.
·
Annals of Allergy Asthma & Immunology
·
20
Hospital‐based costs associated with venous thromboembolism treatment regimens
2008
·
G. MERLI
, C. FERRUFINO
, et al.
·
Journal of Thrombosis and Haemostasis
·
20
PDF
Cost-effectiveness of casirivimab/imdevimab in patients with COVID-19 in the ambulatory setting
2022
·
Nick Jovanoski
, Andreas Kuznik
, et al.
·
Journal of Managed Care & Specialty Pharmacy
·
17
Propensity Score Matching in the Evaluation of Drug Therapy Management Programs: An Illustrative Analysis of a Program for Patients With Hepatitis C Virus
2010
·
Mohamed Hussein
, Joshua S. Benner
, et al.
·
Quality Management in Health Care
·
16
Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis?
2009
·
Steven B. Deitelzweig
, Jay Lin
, et al.
·
Journal of Thrombosis and Thrombolysis
·
15
Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large claims database
2022
·
Mohamed Hussein
, Wenhui Wei
, et al.
·
BMJ Open
·
13
PDF
Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy
2009
·
M.H. Kim
, J. Lin
, et al.
·
Current Medical Research and Opinion
·
13
Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19
2022
·
Jessica J. Jalbert
, Mohamed Hussein
, et al.
·
Infectious Diseases and Therapy
·
9
PDF
The symptoms evolution of long COVID‑19 (SE-LC19): a new patient-reported content valid instrument
2024
·
Diana Rofail
, Selin Somersan-Karakaya
, et al.
·
Journal of Patient-Reported Outcomes
·
6
Reliability and Validity of an Instrument of COVID-19 Patient-Reported Symptoms in Outpatients
2022
·
Diana Rofail
, Pip Griffiths
, et al.
·
JAMA Network Open
·
3
PDF
Real-world Effectiveness of Casirivimab and Imdevimab in Patients With COVID-19 in the Ambulatory Setting: An Analysis of Two Large US National Claims Databases
2022
·
Wenhui Wei
, Dana Murdock
, et al.
·
medRxiv
·
3
PDF
Appropriate VTE Prophylaxis Is Associated with Lower Direct Medical Costs among Medical and Surgical Patients in the United States.
2008
·
Alpesh Amin
, Mohamed Hussein
, et al.
·
Blood
·
3
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double–Blind Trial
2023
·
Selin Somersan-Karakaya
, Eleftherios Mylonakis
, et al.
·
Open Forum Infectious Diseases
·
2
Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV ‐2
2022
·
Mohamed A. Kamal
, Andreas Kuznik
, et al.
·
Clinical Pharmacology & Therapeutics
·
2
PDF
Monoclonal Antibody Treatment, Prophylaxis and Vaccines Combined to Reduce SARS CoV-2 Spread
2021
·
Mohamed A. Kamal
, Andreas Kuznik
, et al.
·
medRxiv
·
1
PDF
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19
2024
·
Thomas D Norton
, Mazhar Thakur
, et al.
·
Journal of the Pediatric Infectious Diseases Society
Patient-Reported Outcomes in COVID-19 Treatment with Monoclonal Antibodies Reveal Benefits in Return to Usual Activities
2024
·
Diana Rofail
, Mohamed Hussein
, et al.
·
Infectious Diseases and Therapy
48. Heart Failure and Impaired Cognitive Function: Findings From the National Health and Nutrition Examination Survey
2024
·
Sophia Fioramonti-Gorchow
, Judith Meadows
, et al.
·
Biological Psychiatry
Show more works
View as search
Works count:
32
Citation count:
569
H-index:
13
I10-index:
14
Year
Topic
Type